Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
– REZZAYO is a novel, once-weekly, next-generation echinocandin indicated for the treatment of candidemia and…